AAAAAA
Results:
1-13
|
Results: 13
Authors:
Slassi, A
Isaac, M
Arora, J
Citation: A. Slassi et al., Novel serotonergic and non-serotonergic migraine headache therapies, EXPERT OP T, 11(4), 2001, pp. 625-649
Authors:
Prisinzano, T
Law, H
Slassi, A
MaClean, N
Demchyshyn, L
Glennon, RA
Citation: T. Prisinzano et al., QSAR studies on 2-(benzyl)imidazolin analogs as h5-HT1D/1B serotonin receptor ligands, MED CHEM RE, 10(5), 2001, pp. 309-317
Authors:
Prisinzano, T
Law, H
Dukat, M
Slassi, A
MaClean, N
Demchyshyn, L
Glennon, RA
Citation: T. Prisinzano et al., Imidazoline-modified benzylimidazolines as h5-HT1D/1B serotonergic ligands, BIO MED CH, 9(3), 2001, pp. 613-619
Authors:
Isaac, M
Slassi, A
Da Silva, K
Arora, J
MacLean, N
Hung, B
McCallum, K
Citation: M. Isaac et al., 5,5-diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitors, BIOORG MED, 11(11), 2001, pp. 1371-1373
Authors:
Guindon, Y
Slassi, A
Bencheqroun, M
Citation: Y. Guindon et al., Influence of N-substituted lactams on acyclic free radical based hydrogen transfer (vol 42, pg 6041, 2001), TETRAHEDR L, 42(49), 2001, pp. 8741-8741
Authors:
Isaac, M
Slassi, A
Da Silva, K
Xin, T
Citation: M. Isaac et al., Synthesis of chiral and geometrically defined 5,5-diaryl-2-amino-4-pentenoates: navel amino acid derivatives, TETRAHEDR L, 42(16), 2001, pp. 2957-2960
Authors:
Lee, M
Rangisetty, JB
Dukat, M
Slassi, A
Maclean, N
Lee, DKH
Glennon, RA
Citation: M. Lee et al., 5-HT6 serotonin receptor binding affinities of N-1-benzenesulfonyl and related tryptamines, MED CHEM RE, 10(4), 2000, pp. 230-242
Authors:
Meng, CQ
Rakhit, S
Lee, DKH
Kambo, R
McCallum, KL
Mazzocco, L
Dyne, K
Slassi, A
Citation: Cq. Meng et al., 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine, BIOORG MED, 10(9), 2000, pp. 903-905
Authors:
Isaac, M
Slassi, A
O'Brien, A
Edwards, L
MacLean, N
Bueschkens, D
Lee, DKH
McCallum, K
De Lannoy, I
Demchyshyn, L
Kamboj, R
Citation: M. Isaac et al., Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: Potential therapeutic applications for epilepsy and obesity, BIOORG MED, 10(9), 2000, pp. 919-921
Authors:
Tsai, YC
Dukat, M
Slassi, A
MacLean, N
Demchyshyn, L
Savage, JE
Roth, BL
Hufesein, S
Lee, M
Glennon, RA
Citation: Yc. Tsai et al., N-1-(benzenesulfonyl)tryptamines as novel 5-HT6 antagonists, BIOORG MED, 10(20), 2000, pp. 2295-2299
Authors:
Slassi, A
Edwards, L
O'Brien, A
Meng, CQ
Xin, T
Seto, C
Lee, DKH
MacLean, N
Hynd, D
Chen, C
Wang, H
Kamboj, R
Rakhit, S
Citation: A. Slassi et al., 5-alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists, BIOORG MED, 10(15), 2000, pp. 1707-1709
Authors:
Isaac, M
Slassi, A
Xin, T
MacLean, N
Wilson, J
McCallum, K
Wang, H
Demchyshyn, L
Citation: M. Isaac et al., 6-bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists, BIOORG MED, 10(15), 2000, pp. 1719-1721
Authors:
Slassi, A
Meng, CQ
Dyne, K
Wang, X
Lee, DKH
Kamboj, R
McCallum, KL
Mazzacco, L
Rakhit, S
Citation: A. Slassi et al., Conformationally constrained 5-(thienyl)tryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine, MED CHEM RE, 9(9), 1999, pp. 668-674
Risultati:
1-13
|